BridgeMD
Tests treatment safety and results for Rhinitis Allergic
Official title Validation of the Efficacy of Air Purifiers in Indoor Environment and Allergic Symptoms in Allergic Rhinitis Patients
ClinicalTrials.gov ID: NCT06890572
What this study is testing
- What it's testing
- This study targets adult patients between the ages of 19 and 60 who were diagnosed with allergic rhinitis caused by indoor inhalation antigens. Patients with moderate to severe and persistent allergic rhinitis who continue to require medication such as antihistamines and nasal spray steroids for allergic rhinitis are the subjects of this study.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 60
You may be able to join if
- adults aged 19 to 60
- A person with moderate-severe persistent allergic rhinitis diagnosed by an allergy specialist or otolaryngologist and maintained without any change...
- Total nasal symptom Score ≥ 8
- Patients with allergic rhinitis caused by indoor inhalation antigen antigens (House dust mites ± If the wheal size of the pet skin test is greater...
- A person who spends at least 8 hours/day per week in the home where the cleaner will be installed
You likely can't join if
- Patients sensitized to seasonal antigens (tree, grass or weed pollen)
- Rhinitis patients caused by causes other than allergic rhinitis (drug rhinitis, vascular rhinitis, infectious rhinitis, etc.)
- Anyone who has required more than 2 weeks of systemic steroid use in the last 3 months
- A person taking antihistamines for reasons other than rhinitis (chronic urticaria, etc.)
- Those with anatomical abnormalities that cause nasal congestion, such as non-segmental curvature and non-segmental species
- A person who has a plan to move during the study period or is scheduled to leave where air purifiers are installed for at least five consecutive days...
See the full eligibility criteria
- adults aged 19 to 60
- A person with moderate-severe persistent allergic rhinitis diagnosed by an allergy specialist or otolaryngologist and maintained without any change in treatment for more than one month
- Total nasal symptom Score ≥ 8
- Patients with allergic rhinitis caused by indoor inhalation antigen antigens (House dust mites ± If the wheal size of the pet skin test is greater than 3mm or the concentration of specific IgE measured by ImmunoCAP ≥...
- A person who spends at least 8 hours/day per week in the home where the cleaner will be installed
- A person with a wi-fi installed in the home where the purifier will be installed
- A person who can read and write in Korean
- A person who fully explains the contents, decides to participate in the study according to his/her free will, and signs a written consent form approved by each agency IRB
- Patients sensitized to seasonal antigens (tree, grass or weed pollen)
- Rhinitis patients caused by causes other than allergic rhinitis (drug rhinitis, vascular rhinitis, infectious rhinitis, etc.)
- Anyone who has required more than 2 weeks of systemic steroid use in the last 3 months
- A person taking antihistamines for reasons other than rhinitis (chronic urticaria, etc.)
- Those with anatomical abnormalities that cause nasal congestion, such as non-segmental curvature and non-segmental species
- A person who has a plan to move during the study period or is scheduled to leave where air purifiers are installed for at least five consecutive days (e.g., travel, business trip, etc.)
- A person who has already used an air purifier within the last three months
- Pregnant women, lactating women, persons lacking decision-making ability, persons accommodated in facilities
- A person whose researcher is deemed unfit to participate in clinical research due to other reasons
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.